Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with prostate cancer and are in the process of having their cancer staged (assessed for spread)
- People whose prostate cancer has shown signs of returning through a rise in PSA blood test levels after previously receiving surgery and/or radiotherapy intended to cure the cancer
- People with high-risk prostate cancer, meaning their Gleason score (a measure of cancer aggressiveness) is 8 or higher, or their PSA level is 20 ng/mL or higher
- People who are able and willing to sign a consent form and agree to their personal data being used for the study
Who may not be able to join:
- People who have bladder, urinary, or other genitourinary conditions that could affect the imaging results or how they are interpreted
- People whose prostate cancer is classified as low- or intermediate-risk
- People whose follow-up scan would need to be done on a different PET/CT scanner than the one used for their first scan
- People who would need an additional PET/CT scan due to poor image quality from issues such as urine retention or excessive movement during the scan
- People who have previously taken part in this trial and would be returning for a repeat scan as a new visit
- People who are unable to give informed consent or who have difficulty making decisions for themselves
- People with a known allergy or sensitivity to the radioactive substance used in the scan or any of its ingredients
- People for whom a PET/CT scan is not suitable — for example, due to severe claustrophobia, very high body weight, or being unable to remain still and cooperate during the scan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michela Moscarino, Technician, IRCCS Università di Bologna, Policlinico di Sant'Orsola
Phone: +390512143179
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Matching Quality of Delayed PET with Standard CT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.